World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Citation

Ward MG, Irving PM, Sparrow MP. How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease? World J Gastroenterol 2015; 21(40): 11331-11342 [PMID: 26525434 DOI: 10.3748/wjg.v21.i40.11331]

Full Article (HTML)

(0) (0) (0)

Please LOGIN to submit a new comment.

Write to the Help Desk

ALL AUTHOR RESOURCES
AI Use Policy
Allegations of Misconduct
Appeals and Complaints
Article Processing Charge
Common Usage of Quantities and Units
Copyright License Agreement
Correction and Retraction
Create an Account
Criteria for Authorship
Editorial Policies
Editorial Process
Ethics Committee
Ethics Statements
Guidelines for Authors
Journals
Language Editing Process for Manuscripts Submitted by Non-Native Speakers of English
Methods of Post-Publication Debate
Open-Access
Publication Misconduct
Quality of Publications
Steps for Submitting Manuscripts
Submit a Manuscript

ALL PEER-REVIEWER RESOURCES
Peer-Review Process
Peer-Reviewer Tracking for Manuscripts
Reviewer Acknowledgment

REFERENCE CITATION ANALYSIS
Find a Category
Find a Contributing Scholar
Find a Journal
Find an Academic Assistant
Find an Article
Find an Article PDF
Subscribe
Today's Articles

ALL PUBLISHER RESOURCES
About the BPG
Advertising and Sponsorship
BPG Home
Company Registration
Contact Us
ICMJE Conformity
Management Team
Membership
Ownership
Permissions
Privacy Policy
Publication Ethics
Publisher
Publishing Credentials
Revenue Sources
Special Statement
Terms of Use

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.